RIDGE Trademark

Trademark Overview


On Thursday, April 6, 2023, a trademark application was filed for RIDGE with the United States Patent and Trademark Office. The USPTO has given the RIDGE trademark a serial number of 97876248. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, May 21, 2024. This trademark is owned by Tenaya Therapeutics, Inc.. The RIDGE trademark is filed in the Advertising, Business and Retail Services and Computer & Software Services & Scientific Services categories with the following description:

Business consulting and business project management in the field of clinical trials, namely, providing information management services; business consulting and management in the field of clinical trials, namely, management and compilation of computerized databases in the field of clinical trials for business purposes and business management of clinical trial execution by providing independent review of clinical trials for business purposes; business consulting and management in the field of clinical trials, namely, business management of clinical trial execution; providing technical business and marketing consulting services in the field of marketing and advertising for clinical trials, verifying clinical trial subject eligibility for clinical trials of others, clinical trial subject recruitment and enrollment for clinical trials of others, and processing business documents relating to clinical trials, and information management services; data management services for use in managing cl...

Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Medical and scientific research, namely, conducting clinical trials for others; Providing information on clinical studies via an interactive website; Consulting services for others in the field of design, planning, and implementation project management of clinical trials

General Information


Serial Number97876248
Word MarkRIDGE
Filing DateThursday, April 6, 2023
Status688 - NOTICE OF ALLOWANCE - ISSUED
Status DateTuesday, May 21, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 26, 2024

Trademark Statements


Goods and ServicesBusiness consulting and business project management in the field of clinical trials, namely, providing information management services; business consulting and management in the field of clinical trials, namely, management and compilation of computerized databases in the field of clinical trials for business purposes and business management of clinical trial execution by providing independent review of clinical trials for business purposes; business consulting and management in the field of clinical trials, namely, business management of clinical trial execution; providing technical business and marketing consulting services in the field of marketing and advertising for clinical trials, verifying clinical trial subject eligibility for clinical trials of others, clinical trial subject recruitment and enrollment for clinical trials of others, and processing business documents relating to clinical trials, and information management services; data management services for use in managing clinical data, provided to medical, pharmaceutical and technology companies in order to assist them with clinical research, clinical trials and applications for drug approval; compilation of statistics and clinical trial data for business purposes; statistical analysis for business purposes; preparing and placing advertisements for others, namely, to recruit subjects for participation in clinical trials; providing referrals of subjects for enrollment in clinical trials
Goods and ServicesProviding medical and scientific research information in the field of pharmaceuticals and clinical trials; Medical and scientific research, namely, conducting clinical trials for others; Providing information on clinical studies via an interactive website; Consulting services for others in the field of design, planning, and implementation project management of clinical trials

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateMonday, May 1, 2023
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, May 1, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameTenaya Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Party NameTenaya Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Trademark Events


Event DateEvent Description
Monday, April 10, 2023NEW APPLICATION ENTERED
Monday, May 1, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, January 2, 2024ASSIGNED TO EXAMINER
Thursday, January 4, 2024NON-FINAL ACTION WRITTEN
Thursday, January 4, 2024NON-FINAL ACTION E-MAILED
Thursday, January 4, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, February 7, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, February 7, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, February 8, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, February 21, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 6, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, March 6, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 26, 2024PUBLISHED FOR OPPOSITION
Tuesday, March 26, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 21, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, November 15, 2024SOU TEAS EXTENSION RECEIVED